Cramer says Biogen's Alzheimer's treatment could be 'the biggest drug ever' as shares soar 30%
Drug maker Biogen announced it is seeking regulatory approval for its Alzheimer's drug, months after it stopped testing the treatment.
Market wire
Latest news on private equity markets
Headlines on the small cap U.S. and Canadian companies we follow, pulled from the wires as they publish. Every story opens at its original source.
Boeing makes progress on 737 MAX, but FAA needs weeks to review
Boeing Co is making progress toward getting its 737 MAX aircraft in the air again but the U.S. Federal Aviation Administration (FAA) will need at least...
McDonald's posts rare profit miss, shares drop
McDonald's Corp missed Wall Street estimates for profit for the first time in two years on Tuesday as more investment to spruce up U.S. restaurants and...
Tips for getting your Medicare drug coverage right during open enrollment
Even if you've been happy with your coverage, be aware that insurance carriers make changes from year to year that can affect the drugs they cover...
Lockheed Martin profit climbs, expects lower cash flow in 2020; shares gain
Lockheed Martin Corp raised its estimate for 2019 earnings on Tuesday as quarterly profit climbed 9.2% amid improved sales of its F-35 fighter jets, sending shares...
Cambridge: Global Regulator Survey Results – Regulation of Alternative Finance is Key to Make Sector Safe to Scale for the Masses
Crowdfund Insider JD Alois Oct 21,2019 The Cambridge Centre for Alternative Finance (CCAF), part of the Judge School of Business at Cambridge University, has partnered with...
VW speeds up production of next generation Golf
Volkswagen will start deliveries of its new Golf hatchback in December after shaving an hour off the time needed to build its flagship model, the board...
S&P 500 rises on upbeat corporate earnings; Travelers weighs on Dow
The S&P 500 rose on Tuesday, bolstered by gains in Biogen and upbeat earnings reports that eased concerns over the fallout from the U.S.-China trade war,...
Infosys loses $6.6 billion in market cap after whistleblower complaints
India's No.2 software services exporter, Infosys Ltd , is probing whistleblower complaints that its top two executives engaged in "unethical practices" to boost short-term revenue and...
Clean getaway: Meat waste joins biofuels at luxury jet show
At the world's biggest industry show in Las Vegas luxury jets are luring buyers with their sleek silhouettes, plush cabins - and increasingly, their use of...
Futures edge higher on upbeat earnings
U.S. stock index futures rose on Tuesday, after another batch of strong corporate earnings eased concerns over domestic growth and the fallout from the prolonged U.S.-China...
How a major U.S. farm lender left a trail of defaults, lawsuits
After completing a credit review in a half-hour phone call, a BMO Harris Bank underwriter cleared $12 million in loans for Ohio corn and soybean producer...
Oil rises on optimism about prospects for a U.S.-China deal
Oil prices rose on Tuesday after China signaled progress in trade talks with the United States, but gains were capped by bearish forecasts of a buildup...
Renault chairman vows to get Nissan alliance back on track next year
Renault Chairman Jean-Dominique Senard is determined to get the carmaker's alliance with Japan's Nissan back on track next year, he said on Tuesday, adding other matters...
Earnings weigh on European stocks, sterling lower before Brexit votes
European shares edged lower on Tuesday as talk of progress in China-U.S. trade talks was offset by mixed corporate earnings, while sterling retreated ahead of another...